期刊文献+

肿瘤纳米磁感应治疗技术发展现状 被引量:3

Frontier Technology The Development Status of Nano-magnetic Induction Therapy of Tumor
下载PDF
导出
摘要 肿瘤是严重威胁人类健康且难以攻克的顽症,针对肿瘤的新技术、新科技层出不穷,但始终难以达到根治肿瘤的目的。近年来,随着分子靶向生物学、肿瘤免疫生物学和纳米技术的发展,肿瘤纳米磁感应治疗技术引起了世界各主要国家研究者们的注意,其具有靶向性高、可联合放化疗、诊断与治疗一体化等优势,有望达到根治肿瘤的目的。 Cancer is a serious threat to human health and difficult to overcome the chronic,an endless stream of new technology for cancer,But always difficult to achieve the purpose of cure cancer;In recent years,with the development of molecular target biology,tumor immune biology and nanotechnology,Nano-magnetic induction of tumor therapy caused the world's attention of researchers,It has targeted high,can be combined radiotherapy and chemotherapy,diagnosis and treatment of the advantages of integration,Expected to reach the purpose of cure cancer.
出处 《中国医疗器械信息》 2011年第10期37-41,共5页 China Medical Device Information
关键词 肿瘤 纳米 磁感应治疗 tumor nano magnetic induction therapy
  • 相关文献

参考文献22

  • 1Johannsen M, Thiesen B, Wust Pet al.Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hypertherrnia. 2010 Jul 23. [Epub ahead of print].
  • 2Sato A, Tamura Y, Sato Net al.Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S- cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release. Cancer Sci. 2010 May 19. [Epub ahead of print].
  • 3Kikumori T, Kobayashi T, Sawaki M et al.Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Breast Cancer Res Treat. 2009 Feb; 113(3):435-41. Epub 2008 Mar 2.
  • 4Kawai N, Futakuchi M, Yoshida T et al.Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate. 2008 May 15;68(7):784-92.
  • 5Shido Y, Nishida Y, Suzuki Y et al. Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model. J Bone Joint Surg Br. 2010 Apr;92(4):580-5.
  • 6Yoshida M, Watanabe Y, Sato Met al.Feasibility of chemohyperthermia with docetaxel-embedded magnetoliposomes as minimally invasive local treatment for cancer. Int J Cancer. 2010 Apr 15;126(8): 1955-65.
  • 7Balivada S, Rachakatla RS, Wang H et al.A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/ shell magnetic nanoparticles: a mouse study. BMC Cancer. 2010 Mar 30;10:119.
  • 8Salloum M, Ma R, Zhu L.Enhancement in treatment planning for magnetic nanoparticle hyperthermia: optimization of the heat absorption pattern, lnt J Hyperthermia. 2009 Jun;25(4):309-21.
  • 9Ciofani G, Riggio C, Raffa Vet al.A bi-modal approach against cancer: magnetic alginate nanoparticles for combined chemotherapy and hyperthermia. Med Hypotheses. 2009 Jul;73(1):80-2. Epub 2009 Mar 9.
  • 10Sabate R, Barnadas-Rodriguez R, Callejas-Fernandez Jet al.Preparation and characterization of extruded magnetoliposomes, lnt J Pharm. 2008 Jan 22;347(1-2): 156-62. Epub 2007 Jul 4.

同被引文献20

  • 1陈建宇,刘庆余,叶瑞心,钟镜联,梁碧玲.滑膜肉瘤MRI影像特征与组织病理学的相关性研究[J].癌症,2005,24(1):87-90. 被引量:27
  • 2lwasaki H, lshiguro M, Ohjimi Y, et al. Synovial sar- coma of the prostate with t(X;18)(p11. 2;q11. 2)[J].Am .J Surg Pathol, 1999, 23: 220-226.
  • 3Shirakawa T, Fujisawa M, Gotoh A, et al. Complete resection of synovial sarcoma of prostatic fascia[J]. U rology, 2003, 61: 644.
  • 4Williams D H, Hua V N, Chowdhry A A, et al. Synovial sarcoma of the prostate[J]. J Urol, 2004. 171 : 2376.
  • 5Pan C C, Chang Y H. Primary synovial sarcoma of the prostate[J]. Histopathology, 2006, 48: 321-323.
  • 6Porter HJ 2nd, Damjanovl, Arnold P, et al. Synovial sarcoma metastatic to the penis and prostate[J]. J Urol, 2001, 166: 605.
  • 7Cheng YC, WangJ H, Shen SH, et al. MRI findings of prostatic synovial sarcoma[J]. Br J Radiol, 2007, 80:e15-e18.
  • 8Bixby S D, Hettmer S, Taylor G A, ct sarcoma in children: imaging features and nignmimics[J]. AJR Am J Roentgenol, 1026 -1032.
  • 9Alhazzani A R, El Sharkawy M S, Hassan H. Primary retroperitoneal synovial sarcoma in CT and MRI[J]. Urol Ann, 2010, 2: 39-41.
  • 10Knosel T, Heretsch S, Ahendorf Hofmann A, et al. TLE1 is a robust diagnostic biomarker for synovial sar- comas and correlates with t(X;18): analysis of 319 ca- ses[J]. Eur J Cancer, 2010, 46: 1170-1176.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部